Bone Marrow Progenitor Cell Therapy-Mediated Paracrine Regulation of Cardiac miRNA-155 Modulates Fibrotic Response in Diabetic Hearts

Agriculture & Biology

• bone marrow cells 100%
• hepatocyte growth factor 98%
• bone marrow 87%
• microRNA 81%
• stem cells 80%
• fibrosis 78%
• myocardial infarction 63%
• therapeutics 62%
• heart 62%
• fibroblasts 28%
• mice 27%
• blood vessels 26%
• infarction 21%
• proto-oncogenes 21%
• angiogenesis 19%
• neutralizing antibodies 18%
• diabetes 17%
• myocardium 17%
• in vitro studies 15%
• protective effect 15%
• incidence 11%
• genes 5%

Medicine & Life Sciences

• Hepatocyte Growth Factor 76%
• Cell- and Tissue-Based Therapy 76%
• Bone Marrow Cells 76%
• MicroRNAs 67%
• Stem Cells 59%
• Heart 52%
• Bone Marrow 47%
• Fibrosis 35%
• Myocardial Infarction 35%
• Fibroblasts 23%
• Primary Myelofibrosis 20%
• Ventricular Remodeling 19%
• Blood Vessels 18%
• Proto-Oncogenes 18%
• Left Ventricular Dysfunction 17%
• Conditioned Culture Medium 16%
• Neutralizing Antibodies 16%
• Left Ventricular Function 15%
• Infarction 13%
• Myocardium 13%
• Down-Regulation 11%
• Incidence 7%
• In Vitro Techniques 7%
• Genes 6%
• Therapeutics 2%

Chemistry

• Antifibrotic 68%
• Conditioned Culture Medium 30%
• MicroRNA 24%
• Protective 16%